SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 229 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $12,790 | +45578.6% | 254,257 | +1081.3% | 0.03% | – |
Q2 2023 | $28 | -26.3% | 21,524 | 0.0% | 0.00% | – |
Q1 2023 | $38 | -44.1% | 21,524 | 0.0% | 0.00% | – |
Q4 2022 | $68 | -99.9% | 21,524 | 0.0% | 0.00% | -100.0% |
Q3 2022 | $105,000 | +18.0% | 21,524 | 0.0% | 0.00% | – |
Q2 2022 | $89,000 | -28.8% | 21,524 | 0.0% | 0.00% | -100.0% |
Q1 2022 | $125,000 | -22.4% | 21,524 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $161,000 | -17.0% | 21,524 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $194,000 | -24.8% | 21,524 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $258,000 | -4.4% | 21,524 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $270,000 | -19.6% | 21,524 | 0.0% | 0.00% | -50.0% |
Q4 2020 | $336,000 | +65.5% | 21,524 | 0.0% | 0.00% | +100.0% |
Q3 2020 | $203,000 | +5.2% | 21,524 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $193,000 | +40.9% | 21,524 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $137,000 | -19.4% | 21,524 | +5.9% | 0.00% | 0.0% |
Q4 2019 | $170,000 | -7.6% | 20,319 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $184,000 | -16.0% | 20,319 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $219,000 | +12.9% | 20,319 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $194,000 | -16.7% | 20,319 | 0.0% | 0.00% | -50.0% |
Q4 2018 | $233,000 | -32.3% | 20,319 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $344,000 | +19.0% | 20,319 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $289,000 | -25.1% | 20,319 | 0.0% | 0.00% | -33.3% |
Q1 2018 | $386,000 | -9.4% | 20,319 | -21.8% | 0.00% | 0.0% |
Q4 2017 | $426,000 | +9.2% | 25,992 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $390,000 | +70.3% | 25,992 | 0.0% | 0.00% | +50.0% |
Q2 2017 | $229,000 | +69.6% | 25,992 | 0.0% | 0.00% | +100.0% |
Q1 2017 | $135,000 | +70.9% | 25,992 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $79,000 | -34.2% | 25,992 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $120,000 | -20.0% | 25,992 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $150,000 | -4.5% | 25,992 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $157,000 | -33.8% | 25,992 | 0.0% | 0.00% | -50.0% |
Q4 2015 | $237,000 | +61.2% | 25,992 | 0.0% | 0.00% | +100.0% |
Q3 2015 | $147,000 | -49.0% | 25,992 | 0.0% | 0.00% | -50.0% |
Q2 2015 | $288,000 | -30.8% | 25,992 | -2.0% | 0.00% | -33.3% |
Q1 2015 | $416,000 | +3.2% | 26,515 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $403,000 | +40.9% | 26,515 | 0.0% | 0.00% | +50.0% |
Q3 2014 | $286,000 | -29.4% | 26,515 | 0.0% | 0.00% | -33.3% |
Q2 2014 | $405,000 | -15.4% | 26,515 | 0.0% | 0.00% | -25.0% |
Q1 2014 | $479,000 | +13.0% | 26,515 | -13.1% | 0.00% | 0.0% |
Q4 2013 | $424,000 | +32.5% | 30,500 | 0.0% | 0.00% | +33.3% |
Q3 2013 | $320,000 | +34.5% | 30,500 | 0.0% | 0.00% | +50.0% |
Q2 2013 | $238,000 | – | 30,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alexandria Capital, LLC | 968,505 | $12,135,000 | 1.23% |
Golden State Equity Partners | 126,608 | $1,586,000 | 0.90% |
McGuire Investment Group, LLC | 272,801 | $3,418,000 | 0.72% |
Lombard Odier Asset Management (Switzerland) SA | 848,429 | $10,631,000 | 0.70% |
Rhenman & Partners Asset Management AB | 765,000 | $9,585,000 | 0.67% |
EMC Capital Management | 72,061 | $903,000 | 0.64% |
WASATCH ADVISORS LP | 10,328,423 | $129,415,000 | 0.58% |
Ceeto Capital Group, LLC | 74,000 | $927,000 | 0.45% |
Fort Sheridan Advisors LLC | 75,945 | $952,000 | 0.38% |
Vanguard Capital Wealth Advisors | 34,580 | $388,679,000 | 0.33% |